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Abstract:  Retinal  development  is  dependent  on  an  accurately  functioning  network  of 
transcriptional  and  translational  regulators.  Among  the  diverse  classes  of  molecules 
involved, non-coding RNAs (ncRNAs) play a significant role. Members of this family are 
present in the cell as transcripts, but are not translated into proteins. MicroRNAs (miRNAs) 
are small ncRNAs that act as post-transcriptional regulators. During the last decade, they 
have been implicated in a variety of biological processes, including the development of the 
nervous system. On the other hand, long-ncRNAs (lncRNAs) represent a different class of 
ncRNAs that act mainly through processes involving chromatin remodeling and epigenetic 
mechanisms.  The  visual  system  is  a  prominent  model  to  investigate  the  molecular 
mechanisms  underlying  neurogenesis  or  circuit  formation  and  function,  including  the 
differentiation of retinal progenitor cells to generate the seven principal cell classes in the 
retina, pathfinding decisions of retinal ganglion cell axons in order to establish the correct 
connectivity from the eye to the brain proper, and activity-dependent mechanisms for the 
functionality of visual circuits. Recent findings have associated ncRNAs in several of these 
processes and uncovered a new level of complexity for the existing regulatory mechanisms. 
This review summarizes and highlights the impact of ncRNAs during the development of 
the vertebrate visual system, with a specific focus on the role of miRNAs and a synopsis 
regarding recent findings on lncRNAs in the retina. 
Keywords: retina; microRNA; non-codingRNA; visual system; neurodegenerative diseases; 
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1. Introduction 
During  the  development  of  the  nervous  system,  a  sophisticated  interplay  between  different 
molecules in an organism takes place to generate the correct cell types at the correct time, allow them 
to migrate to the appropriate places and finally connect to each other in a proper way to ensure normal 
functionality. One of the major challenges has been the characterization of the regulatory network 
underlying these fundamental steps. The visual system, apart from the interest as a sensory system  
per se, has been one of the prominent models to help characterizing general molecular mechanisms in 
neural development. The eye develops from an initial lateral evagination of the diencephalon and a 
subsequent formation of the optic cup [1]. Retinal cells differentiate in a clear chronological order 
from a population of multipotent retinal progenitors to generate the seven principal cell types [2,3]. 
The correct establishment of axial polarity of the retina ensures that retinal ganglion cells (RGCs),  
the only projection neurons of the eye, form synaptic connections with different brain targets in an 
appropriate  retinotopic  manner  [4].  And  finally,  individual  classes  of  retinal  cells  can  be  further 
divided into sub-types that connect to each other within function-specific circuits [5]. To date, many 
protein-encoding genes have been identified, which ensure the correct development of the eye and the 
establishment of connectivity within the retina and with other targets in the nervous system. In addition 
to protein-coding mRNAs however, and different from the well-characterized RNA molecules which 
perform infrastructural and housekeeping roles (such as rRNAs, tRNAs, and snRNAs), a large number  
of  so-called  non-coding  RNAs  (ncRNAs)  were  found  to  be  expressed  in  the  developing  central 
nervous system [6–8]. Emerging data suggest that the enormous number of ncRNAs, which have little 
or no protein-coding potential, contains most of the information that control the expanded regulatory 
framework in eukaryotes, increasing the complexity of such organisms [9]. Intensive studies in the last 
decade led to a distinct classification of ncRNAs, mainly according to aspect of origins, structure and 
biological  functions.  Selected  from  these  different  categories,  we  will  discuss  here  microRNAs 
(miRNAs) and long ncRNAs (lncRNAs). MiRNAs represent a large family of endogenous 21–23 
nucleotide-long  RNAs,  which  regulate  gene  expression  mainly  through  post-transcriptional 
regulation [10]. The generation of miRNAs in a cell has long been viewed as linear and universal to all 
mammalian miRNAs, following therefore a ―canonical‖ pathway (Figure 1). However, recent studies 
have  identified  additional  features  that  do  not  obey  this  simple  miRNA  maturation  pathway. 
Furthermore, it has been shown that the metabolism and function of miRNAs is in turn subject to a 
sophisticated control ([11] and Figure 1). This multistep control and the complexity of the different 
pathways  have  to  be  carefully  taken  into  account  in  order  to  appropriately  interpret  results  from 
experimental perturbations of the system. 
MiRNAs  interact  with  their  mRNA  targets  through  direct  Watson-Crick  base-pairing  of  the  
5′  region  of  the  mature  miRNA—known  as  the  seed  sequence—and  the  3′UTR  of  partially 
complementary mRNAs. This enables the presence of combinatorial effects with other miRNAs and 
RNA-binding proteins that associate with the same target mRNAs. Considering that miRNAs can 
regulate large numbers of targets [12,13] they represent a fundamental feature during the global control 
of spatial-temporal changes in a given cell or organ [14,15]. In addition to identifying the function of 
individual miRNAs, an approach that has been widely used is the removal of the ribonuclease Dicer, 
one of the critical enzymes for miRNA maturation and thus representing a bottleneck in the biogenesis Int. J. Mol. Sci. 2012, 13                       
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pathway [16]. Early studies using this approach showed that miRNAs have a critical role during brain 
development, including eye formation [16]. The subsequent generation of a conditional allele for Dicer 
in  mice  allowed  the  removal  of  this  protein,  and  thus  the  majority  of  miRNAs,  in  a  specific  
spatial-temporal  fashion  using  the  Cre-Lox  technology  [17].  Although  this  method  faces  some 
limitations, the different conditional Dicer-deletions that have been generated in the retina resulted in 
important contributions to the field.  
Figure 1. MicroRNA biogenesis pathway. 
 
In eukaryotic cells most of the miRNAs are generated through the ―classical‖ canonical pathway 
(Figure 1, middle section, black arrows). However, studies carried out in the last few years highlighted 
several exceptions due to the presence of modulators of this canonical pathway, including inhibitors or Int. J. Mol. Sci. 2012, 13                       
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activators (Figure 1, red and green squares) or alternative pathways (left and right sections, purple 
arrows).  In  the  canonical  pathway  (Figure  1,  middle):  MiRNA  genes  are  transcribed  by  RNA 
polymerase II to give rise to long primary transcripts (pri-miRNAs), which form hairpin structures. 
This step is subject to regulation by transcriptional activators or inhibitors (not shown). In the nucleus 
pri-miRNAs are then processed by a protein complex containing the RNase III Drosha, resulting in a 
60–70-nucleotide stem/loop structure with a 3′ overhang (pre-miRNAs). This step can be modulated by 
activators (green box) and inhibitors (red box) that act on the RNA stem/loop structure or on the Drosha 
activity. Furthermore, in some cases, pre-miRNA sequences can be subject to base modifications by an 
editing process. The pre-miRNAs are then exported to the cytosol with the help of Exportin-5, through 
a GTP-dependent process. There, the pre-miRNAs are further processed by the Dicer-TRBP complex 
to  yield  a  21–24  nucleotide  long  miRNA/miRNA*  duplex  molecule.  Also  this  step  is  subject  to 
regulation through inhibitors and activators, acting on the complex and the stem/loop structure. Finally, 
mature miRNAs are loaded into an RNA-induced silencing complex (RISC) that includes Argonaute 
(Ago2).  An  exception  has  been  reported  for  pre-miR-451,  which  can  follow  a  Dicer-independent 
pathway and is directly loaded into the RISC-Ago2 complex after processing by Drosha. The miRNA 
then binds to the 3′ UTRs of specific mRNA targets and depending on its seed sequence, leads either to 
translational repression or to the cleavage and degradation of the target. In the mirtron pathway (Figure 
1, left): Pre-miRNAs can be also generated through an alternative, Drosha-independent pathway. Here, 
miRNA sequences are located in introns of primary transcripts generated by RNA polymerase II. Their 
expression pattern is therefore exactly following the mirtron-harboring gene. The miRNA sequence is 
subsequently spliced out from the primary transcript by the spliceosome and enters then the sequence 
of the canonical pathway. Other RNAs (Figure 1, right): Exceptions to the canonical pathway have 
been also found for transcripts generated by RNA polymerase III. They are first processed in the 
nucleus in a Drosha-independent manner and then transported to the cytosol where they may be subject 
to a Dicer/Ago-dependent pathway. 
Long ncRNAs represent a class of RNA molecules that is fundamentally different from miRNAs  
in their function and in the way the act. In contrast to the short sequences of miRNAs, the transcripts 
for long ncRNAs are usually longer than 200 nt and can even reach more than 100 kilobases, as  
shown for macro ncRNAs [18]. They are one of the most abundant classes of ncRNAs transcribed in  
the genome, being highly expressed in neural tissues [19,20]. Similar to protein-coding genes, the 
transcription  of  lncRNAs  can  be  dynamically  regulated  showing  specific  temporal  and  cell-type 
specific  expression [21,22].  Furthermore,  the  primary  transcript  can  also  be  post-transcriptionally 
modified,  including  5′  capping,  3′  polyadenylation  and  splicing,  as  known  for  conventional  
mRNAs [9,23]. As a consequence of their increased length and sequence, the transcripts of lncRNAs 
are able to form specific secondary structures with clear functional features [24,25]. They have been 
shown to control the cellular gene expression program at multiple levels [26]. However, in contrast to 
miRNAs, only a small number of functional lncRNAs has been described to date. One of the major 
functions appears to be the regulation, both in cis and in trans, of the epigenetic status of proximal and 
distal  protein—coding  genes  through  the  recruitment  of  chromatin-remodeling  complexes  [27,28]. 
However an individual lncRNA can act, in turn, at several levels of gene expression making it difficult 
to attempt a simple classification [26]. In the developing retina the expression of several lncRNAs  Int. J. Mol. Sci. 2012, 13                       
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has  been  described,  even  though  the  characterization  of  clear  functions  remain  largely  to  be  
elucidated [6,29,30]. 
Here, we provide an overview of recent advances in understanding the role of ncRNAs during 
visual  system  development  and  function.  In  the  first  part  we  focus  on  the  family  of  miRNAs, 
summarizing the studies that have been carried out to profile their expression pattern in the vertebrate 
retina  and  the  experiments  aimed  at  their  functional  characterization  during  normal  retinal 
development. Finally, we also discuss the emerging roles of lncRNAs in the retina.  
2. Identification of miRNAs in the Retina 
Many large-scale efforts applying different strategies, such as small RNA isolation followed by 
cloning or deep sequencing and small RNA library sequencing, have been undertaken to discover 
miRNAs in a variety of species, including in mammalian genomes [31,32]. The number of individual 
miRNAs identified has therefore been steadily increasing and ranges in the thousands today [33–36]. 
In  particular,  there  are  currently  more  than  1500  human  miRNA  and  over  800  mouse  miRNA 
sequences deposited in the miRbase database [37,38]. One of the first studies that included the mouse 
eye as a source tissue identified 8 specific miRNAs [39], whereas a systematic study in zebrafish 
identified at least 15 miRNAs in the eye [40]. These early studies showed that a considerable number 
of miRNAs are expressed in a tissue-specific or even cell-type specific manner. It is therefore not 
surprising that several laboratories have consequently analyzed the miRNA transcriptome in the retina. 
Some  of  these  studies  used  qPCR  or  cloning  approaches  and  therefore  reported  simple  miRNA 
expression profiles, without analyzing the expression patterns in more detail [41–43]. However, with 
the development of more applicable hybridization techniques for small RNA probes, some reports 
started to include also retinal expression patterns [44–47] in addition to studies using different retinal 
laminae isolated by laser capture microdissection as a source [48]. Interestingly, comparing data from 
different expression profiling reports, it became clear that a particular miRNA cluster (miR-183/96/182) 
was specifically expressed not only in the retina [43], but also in the inner ear [49] and the dorsal root 
ganglion  [50],  suggesting  a  ―sensory-organ  specific  miRNA  cluster‖  [43].  Further  investigation 
showed that this cluster is indeed also expressed in the olfactory and tongue epithelia and that the 
genes for these three miRNAs are located within a 4 kb genomic region on mouse chromosome 6qA3 
and are transcribed as a single polycistronic pri-miRNA, an arrangement conserved from C. elegans to 
human [43,51]. It was found that the members of this cluster miR-183/96/182 are all expressed in rods, 
cones and bipolar cells, whereas other miRNAs follow different, lamina-specific expression patterns, 
for  example  miR-181a  in  RGCs  and  amacrine  cells  [45,46,52]  or  let-7d  in  bipolar  and  amacrine 
cells [52].  
Based on the early miRNA expression profiling reports from mouse, human [39] and zebrafish [40], 
the  Banfi  laboratory  described  initially  a  set  of  7  eye-specific  miRNAs,  including  their  spatial 
expression pattern in the retina [45]. A particular advance compared to other studies was the inclusion 
of different developmental stages revealing changes in cell and lamina-specific expression of certain 
retinal miRNAs over time. The same group increased their efforts using a large-scale approach that 
resulted in the generation of a miRNA expression atlas of the mouse eye, named miRNeye [53]. This 
fully searchable atlas contains high-resolution images of in situ hybridizations from over 200 miRNAs Int. J. Mol. Sci. 2012, 13                       
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at 4 different stages (E16.5, P0, P8 and P60). It is therefore a valuable resource in order to study 
possible functions of miRNAs in the eye from development to adult.  
3. Function of MicroRNAs in the Visual System 
MicroRNAs have been identified to play important roles in almost all biological processes, from 
early neural developmental events, including neurogenesis or cellular differentiation up to later aspects 
such as synapse maturation or function [54,55]. One of the main challenges however still in the field  
is  to  attribute  clear  roles  to  individual  miRNAs.  An  obvious  complication  is  the  high  number  of 
candidate target genes that can be found for each miRNA using different bioinformatics software, such 
as TargetScan, miRanda or PicTar [56–58]. In addition, these algorithms produce only predictions of 
possible targets and the actual binding of a miRNA to a 3′UTR of a candidate target mRNA has still  
to  be  confirmed  empirically.  A  second  difficulty  is  that  miRNAs  generally  rather  ―fine-tune‖  the 
protein output of a cell and therefore a loss of function phenotype for a single miRNA may be very 
subtle [12,13].  Finally,  the  highly  specific  regulation  of  the  miRNA  maturation  pathway  and  the 
variation  of  the  degradation  rate  for  each  miRNA  increase  the  variability  and  the  complexity  of 
targeted gain and loss of function studies [11]. Many laboratories therefore tried to overcome these 
difficulties through a complete (or at least substantial) deletion of miRNAs, in order to study the 
general role for these molecules in a particular system or pathway. 
3.1. Dicer Deletions 
Several studies to date have used this approach to delete Dicer in a spatial-temporal fashion the 
visual system. As discussed above, Dicer is a ribonuclease III and one of the essential enzymes for the 
maturation  of  most  miRNAs  (Figure  1).  Therefore,  the  deletion  of  Dicer  leads  to  a  lack  of  such 
miRNAs  and  enables  the  analysis  of  a  system  in  the  absence  of  most  miRNAs.  However,  it  is 
important to note that there are Dicer-independent pathways to generate functional miRNAs ([11] and 
Figure 1) and that studies using Dicer deletions do not show a 100% loss of all miRNAs. The straight 
deletion of Dicer in mice leads to an embryonic lethal phenotype at E7.5 mostly due to a depletion of 
stem cells in the embryo [59]. The generation of a conditional Dicer allele in mice made it possible to 
circumvent these problems and delete Dicer by crossing with lines that express the Cre-recombinase 
under the control of specific promoters [17].  
The first report analyzing a conditional Dicer deletion in the retina used the Chx10-cre line [60]. 
This  BAC-transgenic  mouse  line  harbors  a  Cre-GFP  cassette  under  the  control  of  the  Chx10 
promoter [61] and leads to a mosaic expression of the Cre-recombinase in the retina. As a consequence, 
retinal cells (although not all of them) lack functional Dicer protein [60]. The authors reported that 
retinae from these mutant mice showed normal lamination and no alteration in the generation of the 
different retinal cell types during embryonic and early postnatal development. However, at later stages, 
the mutant mice generated photoreceptor rosettes that had been described previously in pathological 
retinal conditions, associated with degeneration and/or abnormal proliferation of retinal cells [62]. 
Further  analysis  showed  no  increase  in  proliferation  and  that  the  phenotype  was  attributed  to  a 
degenerative phenotype. After postnatal day (P) 16, the mutant retinae became increasingly affected by 
degeneration,  showing  a  higher  number  of  rosettes  and  disorganization  of  the  retinal  laminae.  In Int. J. Mol. Sci. 2012, 13                       
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parallel, the mutant mice showed abnormalities in their ERG responses probably as a result of the 
retinal degeneration [60]. The relatively late onset of apoptosis after Dicer deletion was surprising, 
since  studies  carried  out  in  several  other  systems  before  and  since  then  have  shown  an  almost 
immediate cell death phenotype upon loss of Dicer [17,63–65]. 
A different study in the same year reported the downregulation of Dicer in the Xenopus retina  
by  using  morpholinos  that  were  electroporated  into  retinal  progenitor  cells  [66].  Here,  the  Dicer  
knock-down led to photoreceptor rosettes and increased retinal cell death similar to the phenotypes 
seen in the Chx10-cre; Dicer
fl/fl mice. In addition however, the eyes appeared to be overall smaller in 
some morphants with strong defect in retinal lamination. Furthermore translation of some of the genes 
involved in controlling retinal cell fate, such as Xotx5 and Xotx2, was delayed, prompting the authors 
to suggest that miRNAs are controlling the cell clock machinery for timing the retinal neurogenesis [66].  
A more detailed analysis on the generation of different retinal cells upon Dicer deletion came from 
the Reh laboratory [67]. Here, the floxed Dicer allele was used in combination with a Pax6-α-cre line, 
that expresses the Cre-recombinase in the nasal and temporal distal portions of the retina starting at 
around E10.5 [68]. In contrast to the earlier study in mouse [60], the authors detected aberrancies 
already starting at E16. Using a number of retinal cell-type specific markers it was shown that the 
deletion of Dicer leads to a overproduction of early generated retinal cell populations, such as RGCs 
and horizontal cells, and on the other hand, a downregulation of late progenitor cells [67]. Probably as 
a consequence of the latter, the Dicer-deleted areas of the retina show a decrease of the late generated 
cell types (amacrine cells and rod photoreceptors). These results suggest that Dicer (and therefore 
probably miRNAs) has an important function in the regulation of progenitor competence. In addition, a 
general increase in apoptosis was detected from early developmental stages onwards, which extends 
postnatally so that by P8 all the Dicer—negative cells have disappeared [67]. Finally, the authors 
found that the retinal progenitor cells in Dicer mutant mice failed to express the transcription factor 
Asc1, a major regulator of Notch signalling components, suggesting that this pathway may be—at least 
in part—responsible for the detected phenotypes. This hypothesis was subsequently confirmed by a 
recent study from the same authors showing that Dicer mutant retinae exhibit a decrease in Notch 
signalling [69]. Indeed, by crossing the conditional Dicer mice into a mouse line that constitutively 
expresses  the  Notch  intracellular  domain—therefore  generally  increasing  Notch  signaling—they 
observed a restoration of normal horizontal cell numbers. However, other major phenotypes, such as 
the increased generation of RGCs or the competence of retinal progenitor cells were not rescued, 
suggesting that the loss of Notch signalling in Dicer mutants has only consequences for specific retinal 
cell types [69]. Changes in the Notch signalling components (and Hedgehog components) upon Dicer 
deletion were previously reported in a parallel study using the same Pax6-α-cre driver in combination 
with  the  floxed  Dicer  allele  [70]  to  generate  a  retina-specific  loss  of  function.  Here,  the  authors 
investigated the role of Dicer in the formation of anterior structures of the optic cup and specifically 
the generation of neural and non-neural tissues during eye development. In addition to the α-cre line, 
the authors used two other Cre-lines, the Tyrp2-cre and Pou4f3-cre to delete Dicer in pigmented retinal 
cells and in postnatal non-pigmented ciliary body plus the iris pigmented epithelium, respectively. This 
resulted in a general increase of apoptotic cells in Dicer-deficient regions, consistent with the findings 
from earlier studies. Further investigation of the mutant mice showed an aberrant patterning of the 
distal portions of the optic cup, where usually neural and non-neural progenitor cells reside to create Int. J. Mol. Sci. 2012, 13                       
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the two different compartments, the neural retina and the ciliary body. The mispatterning in the Dicer 
mutants resulted in a loss of a clear border between these compartments and furthermore, defects in iris 
and ciliary body formation were detected upon loss of Dicer [70].  
A  different  aspect  of  visual  system  development  was  analyzed  in  a  study  by  Pinter  and  
Hindges [64], which focused on RGC axon outgrowth. The visual system has for a long time been one 
of the major systems to investigate neural circuit formation, including axon pathfinding decisions at 
the midline, topographic map formation, axon branching and synaptogenesis [4,71,72]. Here, the authors 
used a mouse line that expresses the Cre-recombinase under the control of the Rx promoter [73]. The 
retinal homeobox (Rx) gene is an eye field transcription factor that is essential for eye formation [74] 
and its expression starts at around E7.5 in the anterior neural plate. As a consequence, conditional 
alleles are deleted in all cells that lead to the development of the retina from the start of eye field 
specification. The study showed that mutant mice exhibited severe micropthalmia, detectable from the 
time  of  eyecup  closure  onwards,  combined  with  a  wave  of  apoptotic  cells  peaking  at  E13.5. 
Interestingly however, the overall structure of the eye, including the formation of the cup and the 
closure of the optic fissure was normal, suggesting that miRNAs and Dicer are not involved in these 
early morphogenic processes [64]. RGCs were found to send out axons correctly through the optic disc 
to form the optic nerve. However, in the optic fiber layer inside the retina, as well as in the optic tract 
at the ventral hypothalamus, it was apparent that the RGC axons are defasciculated. The detection of a 
general lack of adhesion upon Dicer deletion is consistent with other findings showing that Dicer is 
essential for the adhesion of epithelial cells in the eye or lung and in kidney cell types [70,75,76], 
suggesting  a  general  role  for  miRNAs  for  this  function.  The  main  phenotype  concerning  axon 
pathfinding however, was seen at the optic chiasm, with a aberrant segregation between ipsi- and 
contralateral projections, combined with a high number of axons turning at the midline and growing 
into the contralateral eye, as well as some axons extending abnormally into the diencephalon [64]. 
These phenotypes were not the result of a mispatterning of the eye (or the chiasm), suggesting that 
miRNAs have  direct functions in  intracellular processes  needed for axon growth and  pathfinding. 
However, Dicer-negative RGC axons are able to initially innervate correctly their major targets, the 
superior colliculus and the lateral geniculate nucleus (Maiorano and Hindges, unpubl. obs.) and further 
experiments are ongoing to investigate the role of Dicer in retinotopic map formation.  
A similar early conditional deletion of Dicer was described recently, where the authors use a mouse 
line in which the coding region of Foxg1, a transcription factor expressed from E8.5 onwards in the 
mouse telencephalon and optic vesicle, has been replaced by the Cre-recombinase [77]. Again, a high 
rate of cell death was reported in the developing retina, in addition to micropthalamia associated with 
depigmentation and the absence of the lens. However, here the phenotype is more complicated to 
dissect and to contribute uniquely to the action of miRNAs (or Dicer), since the Cre-positive cells in 
the lens and the nasal portion of the eye also loose at least one functional copy of Foxg1 [78]. 
The  most  recent  report  using  the  conditional  Dicer  allele  in  combination  with  a  mouse  line  
that  expresses  Cre  in  retinal  progenitors  from  around  E10.5  onwards  (Dkk3-cre)  showed  again  a 
microphthalmia  phenotype,  coupled  with  an  increase  in  apoptosis  and  abnormal  differentiation  of 
several cell types, in line with previous reports. In vitro re-aggregation experiments demonstrated that 
these effects are cell-autonomous [79].  Int. J. Mol. Sci. 2012, 13                       
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Table 1. Conditional Dicer deletion studies in the mouse visual system. 
Cre-line 
Onset  
of Cre-
expression 
Location of  
Cre-expression  
(visual system) 
Survival 
(homozygotes) 
Reported phenotypes  Reference 
Chx10-cre 
[61] 
E10.5  Retinal progenitors, 
mosaic 
Normal  Photoreceptor rosettes, 
apoptosis, abnormal ERG 
responses 
Damiani et al., 2008, 
[60] 
Rx-cre  
[73] 
E7.5  Eye-forming tissues, 
anterior neural plate 
Die at P0  Micropthalmia, apoptosis, 
axon guidance defects 
Pinter & Hindges 
2010, [64] 
Pax6--cre 
[68] 
E10.5  Nasal and temporal 
distal regions of the 
retina 
Normal  Micropthalmia, apoptosis, 
increase of early retinal 
cells, decrease of late 
progenitors 
Georgi & Reh, 2010, 
[67] 
        Detached iris pigmented 
epithelium, hypoplastic 
ciliary body 
Davis et al., 2011, 
[70] 
Tyrp2-cre 
[80] 
E9  From E11 in pigmented 
retinal cells, at late 
embryogenesis in 
presumptive pigmented 
epithelia of the ciliary 
body and the iris and in 
the muscles/stroma of 
iris; (detectable from E9 
onwards in eye, 
forebrain and DRGs); 
Poor at adult 
stages  
Microphthalmia, most iris 
tissues missing, 
hypoplastic ciliary body 
Davis et al., 2011, 
[70] 
Pou4f3-cre 
[81] 
P1  Non-pigmented ciliary 
body and iris pigmented 
epithelium 
Die soon after 
birth (most) 
Detached iris pigmented 
epithelia, hyperplastic 
ciliary body 
Davis et al., 2011, 
[70] 
Foxg1-cre 
[78] 
E8.5  Optic vesicle, lens, 
telencephalon, olfactory 
epithelium, ear, foregut, 
isthmus 
Die just before 
birth 
Microphtalamia mostly 
associated with high 
apoptosis and 
depigmentation in nasal 
retina, lens missing. 
Kersigo et al., 2011, 
[77] 
Dkk3-cre 
[82] 
E10.5  Retinal progenitors  Die 4–6 weeks 
postnatal 
Micropthalmia, apoptosis, 
defects in retinal cell 
differentiation 
Iida et al., 2011, [79] 
In summary, these  data resulting from the conditional deletion of Dicer have lead to multiple 
interesting phenotypes discovering possible functions of miRNAs in retinal development and cell 
maintenance. One has to, however, take some caution. We are not yet at a point to fully understand all 
the functions of Dicer in the cell and therefore cannot automatically attribute all phenotypes seen in 
Dicer mutants exclusively to miRNA function. More work has to be done in the analysis of individual 
miRNAs, miRNA families, or pathways specific to miRNAs in order to get unambiguous data. This 
point is supported for example by findings from a recent study investigating the molecular basis for Int. J. Mol. Sci. 2012, 13                       
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geographic atrophy (GA), an advanced form of age-related macular degeneration (AMD) where cells 
of  the  retinal  pigmented  epithelium  (RPE)  degenerate  [83].  The  authors  detected  lower  levels  of 
DICER1 in RPE cells of humans with GA. Dicer deletion in mouse RPE cells by expressing the  
Cre-recombinase under the RPE-specific BEST1 promoter (using an Adeno-associated viral vector) in 
a  Dicer
fl/fl  background lead  to  specific  cell  degeneration. A  first  possible  conclusion  was that  the  
lack of miRNAs is responsible for the degenerative effects. Further analysis however showed that this 
was not the case, since the injection of the same AAV-BEST1-cre vector into other mouse models 
where  different  genes  essential  for  the  miRNA  biogenesis  pathway  were  conditionally  targeted, 
including Drosha
fl/fl, Dgcr8
fl/fl or Ago2
fl/fl mice [84–86], did not result in similar RPE degeneration. 
Surprisingly, Dicer was found to have a completely different function, namely in protecting the RPE 
cells from toxic RNA elements. It was shown that primary transcripts from the Alu elements present in 
the human genome (B1/B2 RNA in mice) are inducing cell death in the RPE and that in the normal 
situation Dicer cleaves these approx 300 nucleotide-long sequences into small, non-toxic fragments. 
Dicer down-regulation in GA therefore leads to an accumulation of Alu RNA (or B1/B2 RNA in mice) 
that induces cell death [83]. As discussed above, all studies to date using conditional Dicer deletions 
reported a large increase in apoptosis in the affected tissue. Considering the data from the AMD model, 
it remains to be seen if cell death in other tissues than the RPE, is indeed exclusively a consequence of 
the lack of miRNAs or if Dicer here also—at least in part—plays a wider role, for example through 
clearing the cells of toxic RNA. Interestingly, possible additional roles of Dicer were already pointed 
out in the first report of a retina-specific Dicer deletion [60]. These results make a strong case for using 
other  approaches  in  addition  to  Dicer-deletions  to  globally  delete  miRNAs  in  order  to  analyze 
unambiguously  their  function  in  a  system,  for  example  by  using  different  conditional  deletions 
affecting the miRNA pathway. 
3.2. Functions of Individual miRNAs in the Visual System 
Only a few reports exist where the role of a one particular or a small group of miRNAs have been 
investigated in the visual system. In Xenopus, a set of miRNAs, miR-129, miR-155, miR-214 and 
miR-222, was identified that targets the otx2 and vsx1 genes and leads to their translational inhibition. 
These two genes are essential to specify late-born bipolar cells in the retina [87–89] and although 
transcribed already in early progenitors, their translation is not detected until later stages. The authors 
found  that  the  cell-cycle  dependent  expression  of  the  four  miRNAs  is  needed  to  inhibit  early 
translation  of  these  homeobox  transcription  factors  until  the  appropriate  time  to  generate  bipolar 
cells [90]. A different study performed in Xenopus investigated the role of the brain-specific miR-124 
during  retinal  development  [91].  Although  a  reliable  down-regulation  of  miR-124  could  not  be 
achieved, the overexpression of this miRNA resulted in an elongated retina coupled with a shorter 
optic  stalk  and  an  inhibition  of  retinal  cell  proliferation.  As  a  possible  direct  target,  Lhx2  was 
identified [91]. The down-regulation of an other miRNA, miR-24, in the Xenopus eye lead to increased 
apoptosis  and  a  small  eye  phenotype,  whereas  its  over-expression  was  sufficient  to  prevent  cell 
death [92].  RNA-binding  assays  identified  the  pro-apoptotic  factors  caspase9  and  apoptosis  
protease-activating factor 1 (apaf1) as direct target genes, suggesting that miR-24 acts as an important 
regulator of cell death during retinal development by repressing an apoptotic program [92].  Int. J. Mol. Sci. 2012, 13                       
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In mouse, a study analyzed the genetic deletion of miR-182, a miRNA highly abundant in the retina 
that belongs to the miR-183/96/182 cluster discussed above [93]. Given its strong expression in the 
retina, one would have predicted a clear phenotype upon deletion of the gene. However, the resulting 
miR-182 mutant mice did not reveal any structural abnormalities in the retina during development  
and throughout the first weeks after birth [93]. Furthermore, no significant changes in global gene 
expression could be detected in the miR-182 loss of function mice, using microarray profiling. It 
remains to be shown if these mice show any physiological phenotypes in the retina. 
Finally, we summarize here some recent exciting findings that investigated the role of specific 
miRNAs not directly related to a function in the retina, but rather in the general visual system. The  
first  study  came  from  the  Filipowicz  lab  [94]  and  performing  a  detailed  investigation  on  the  
miR-183/96/182 cluster and on miR-204 and miR-211, two miRNAs located in introns of two genetic 
loci  encoding  cation  channels.  The  miR-183/96/182,  mostly  expressed  in  photoreceptors,  and  the  
miR-204/211  enriched  in  the  cells  of  the  inner  nuclear  layer  showed  a  highly  dynamic  profile  of 
expression, being up-regulated in light condition and down-regulated upon dark adaptation. Interestingly, 
the authors showed a surprisingly fast turnover of miRNA molecules in the order of an hour, against the 
previous general view of a very slow miRNA turnover in cells [95]. The rapid turnover was shown to  
be  activity-dependent  and  resulted  from  a  fast  decay  coupled  to  a  fine  regulation  of  Pri-miRNA 
transcription upon light adaptation. In turn they regulate neuronal activity through a pathway involving 
the voltage-dependent glutamate transporter SLC1A1 and the sodium/potassium transporting ATPase 
ATP1B3 [94]. Interestingly, the results in this study suggest not to be visual system specific, but rather 
represent a general mechanism for activity-dependent turnover rates for neuronal miRNAs, enabling 
fast changes in mRNA translation for example in dendritic spines.  
Two recent reports described the crucial role of miR-132 in the plasticity of the mouse visual  
cortex during the ―sensitive period‖ shortly after eye opening [96,97]. Independently, they showed that  
pri-miR-132 transcription is regulated at epigenetic levels by activity-dependent mechanism, activated 
upon light induction. Through in vivo gain-and loss-of-function approaches using miR-132 mimics [96] 
and  miR-132 sponges [97] the authors showed a  recovery of plasticity and  synaptic development 
concerning binocular area of visual cortex and a prevention of ocular dominance shift, respectively,  
in  mice  with  monocular  deprivation.  These  experiments  showed  that  light-  (i.e.,  activity)  induced  
miR-132 levels are crucial for ocular dominance plasticity during the critical period in visual cortex.  
4. MicroRNAs and Retinal Diseases 
Studies over the last decade have clearly established a link between miRNAs and diseases within 
and outside the nervous system [98,99]. A particular focus has been the involvement of this family of 
non-coding RNAs in neurodegeneration [100], where the majority of data available is based on either 
linkage analysis of mutations in miRNAs or their 3′UTR target binding sites and the disease or simply 
on profiling miRNAs in different diseases. In the retina, studies have been shown that different mouse 
models of retinitis pigmentosa (RP) exhibit altered miRNA expression profiles [52,101]. The authors 
found that all the members of the miR-183/96/182 cluster are down-regulated in RP mice, whereas 
miR-1, miR-133 and miR-142 are up-regulated. Computational analysis has resulted in a long list of 
possible direct and indirect targets for these miRNAs, but the clear mechanisms how the small RNAs Int. J. Mol. Sci. 2012, 13                       
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lead to the retinal degeneration remain to be elucidated. Similar profiling experiments have been done 
in hypoxia-induced retinal and choroidal neovascularization, because of the link of these processes to 
several diseases including age-related macular degeneration and diabetic retinopathy [102]. The authors 
identify seven miRNAs that are substantially increased and three that are substantially decreased in these 
mouse models. Injection of pre-miR-31, -150 or -184 significantly reduced retinal neovascularization, 
and injection of pre-miR-31 or -150 significantly reduced choroidal neovascularization, although no 
clear link to possible target genes has been established in vivo so far [102].  
As discussed already above, in a specific form of age-related macular degeneration a causal effect 
has been demonstrated for Dicer, but surprisingly in relation to a miRNA-independent function [83]. 
Therefore changes in miRNA profiles in a particular disease can obviously be due to a secondary 
effect and not represent the underlying cause for the development of the disease. More work is needed 
to establish the causal relation between miRNAs and the disease. However, independent of this, the 
possibility remains to use such expression profiles as biomarkers.  
5. Long Non-Coding RNAs in the Visual System 
Several  studies  in  the  last  decade  have  lead  up  to  the  identification  of  more  than  a  thousand  
long non-coding RNAs (lncRNAs) [103] some of which are specifically expressed in the nervous 
system [104]. They are functionally clearly distinct from the miRNAs discussed above. Many lncRNAs 
are also subject to a specific post-transcriptional modification such as splicing, polyadenylation and 5′ 
capping, similar to conventional mRNA processing [105]. A difference to the shorter miRNAs is that 
lncRNAs can control every level of the gene expression pathway, such as chromatin modification  
and transcriptional control in addition to post-transcriptional regulation [19]. Such modulation can be 
carried out through cis- and trans-acting mechanisms [106]. Recently a database has been developed 
grouping together information from several lncRNAs, including some expressed in the retina [29]. 
In  most  cases  that  have  been  characterized  for  the  developing  retina,  lncRNAs  share  the  5′  
cis-regulatory element with protein-encoding genes but they are transcribed in a head-to-head divergent 
way.  Here  the  lncRNAs  are  named  natural  antisense  transcript  (NAS)  or  opposite  sense  transcript  
(OST) [30,107]. Many retinal homeodomain factors that are critical during retinal development have 
NAS/OST associated with their transcriptional unit, including Six3, Pax6, Six6, Vax2, Otx2, Pax2 and 
Rx [107,108]. Studies on such NAS/OST revealed the presence of many isoforms suggesting a detailed 
transcriptional and post-transcriptional regulation. Some of the isoforms are also translated, however 
the functions of the resulting proteins are unknown [107]. The NAS/OST expression pattern can either 
perfectly overlap with [109] or can be absolutely different from [107] the partnered protein-coding 
transcript.  In  several  cases  perturbation  of  protein  transcript  levels  affected  also  the  partnered 
NAS/OST level of expression as seen for Vax2 [107]. A study by the Blackshaw laboratory described 
that for 100 transcription factors expressed during retinal development, no less than 35 are NAS/OST 
associated  [30].  Considering  the  vast  data  on  lncRNA  expression,  it  is  surprising  that  only  in  a  
few cases the function of lncRNAs have been characterized. Recently, the Banfi laboratory performed 
an elegant functional study on the activity of the opposite strand transcript Vax2os during retinal 
development [110]. From the 5 different isoforms  present, the authors focused their study  on the 
strongest expressed isoform Vax2os1. They first showed that Vax2os1 expression, similar to the sense Int. J. Mol. Sci. 2012, 13                       
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Vax2 transcript, is localized in the ventral retina during mouse embryogenesis and strongly down 
regulated during postnatal stages. However, unlike Vax2, Vax2os1 is mainly expressed in the outer 
neuroblastic layer (oNBL) and is again upregulated in adult animals in the ventral outer nuclear layer 
(ONL). Through functional analysis using a gain-of–function approach, the authors demonstrated that 
overexpression of Vax2os1 in retinal proliferating neuroblasts results in an alteration of normal cell 
cycle progression of the photoreceptor progenitor cells toward their final differentiation. In particular, 
they demonstrated a delay in the differentiation of the photoreceptor progenitor cells upon Vax2os1 
overexpression. This therefore suggests that lncRNAs can act as regulators of cell cycle progression 
during cell differentiation. However, further studies need to be performed in order to identify in detail 
the molecules that interact with such lncRNAs and the underlying mechanisms.  
Another example, although in a model different from the retina, is Evf-2, a lncRNA associated with 
the Dlx5/6 locus (encoding two homeodomain transcription factors expressed in retinal progenitors). 
Through an interaction with DLX2, another Dlx family member, Evf-2 can regulate in trans the Dlx5/6 
transcription [111]. A recent study characterized the Six3 opposite strand transcript (Six3OS) in the 
developing mouse retina [112]. The data shows that Six3OS plays an important role in retinal cell 
specification. Furthermore, using gain- and loss-of-function experiments, the authors illustrate that 
Six3OS  does  not  control  Six3  expression  levels  but  rather  regulates  Six3  activity,  suggesting  an 
interaction  in  trans.  Binding  studies  suggest  that  Six3OS  acts  through  the  recruitment  of  histone 
modification  enzymes  to  Six3  target  genes  [112].  Several  possible  interactions  in  trans  between 
lncRNAs and their own or different loci have been hypothesized for the retina, but are still subject to 
investigation [30]. Additional evidence of genetic regulation by lncRNAs in trans outside the retina 
exists for example in Drosophila, where ncRNAs of trithorax response elements recruit epigenetic 
modulators to the specific location of ultrabithorax [30,113,114].  
Other cases where lncRNAs may regulate related protein-coding genes in cis through a mechanism 
of transcriptional facilitation or interference, have been described in yeast, where for example the 
Serine-mediated expression of the intergenic transcript SRG1 represses an adjacent gene SER3, which 
is involved in serine biosynthesis [115], and in pituitary cells where a 5′ locus control region activates 
the transcription of adjacent genes [116]. These results leave the possibility for similar cis-mechanisms 
present also in the retina [30].  
In addition, lncRNAs that are not located near protein-coding genes are also expressed in the retina. 
For example the lncRNA Tug1 has been identified as a regulator of rod photoreceptor development, 
even  if the exact  mechanism has  not  yet been characterized  [117].  Furthermore, the twin  nuclear 
localized lncRNAs Xist and Tsix (regulators of X chromosome inactivation) are expressed in a subset 
of retinal cells in the outer and inner neuroblastic layers during development, keeping a low expression 
level in some RGCs and photoreceptor cells upon differentiation. However, neither the role nor  a 
possible  correlation  with  the  X-chromosome  inactivation  pathway  of  Xist/Tsix  in  these  cells  has  
been clarified [108]. The retinal non-coding RNA 2 (RNCR2), expressed widely in developing nervous 
system,  represents  0.2%  of  all  polyadenylated  RNAs  in  the  neonatal  retina.  RNCR2  negatively 
regulates amacrine differentiation and development of Muller glia cells. Nevertheless, also in this case, 
the underlying molecular mechanism remains unclear [118].  Int. J. Mol. Sci. 2012, 13                       
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In the future, the use of high-throughput sequencing and microarray hybridization approaches in 
combination with functional in vitro and in vivo studies should shine some more light on the role of 
lncRNAs during retinal development and functional maintenance.  
6. Conclusion 
Considering the relatively short time since the initial discovery of non-coding RNAs, the studies to 
characterize their function have resulted in a large amount of novel data and successfully pushed the 
field forward. However, new findings also show that the system is probably more complex than initially 
thought. In the visual system we have made steady progress in characterizing miRNAs and lncRNAs 
and linking them to function, although for many there is still a gap present regarding their precise 
action or their actual target genes. For the future, it will be both challenging and exciting to discover 
much more about the ncRNAs involved in the complex regulatory mechanisms to generate a fully 
functional retina, including its connectivity and physiological properties. 
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